France Immunoassay For Neurological Biomarkers Market Size & Outlook
France immunoassay for neurological biomarkers market, 2018-2030 (US$M)
Related Markets
France immunoassay for neurological biomarkers market highlights
- The France immunoassay for neurological biomarkers market generated a revenue of USD 330.6 million in 2023 and is expected to reach USD 786.5 million by 2030.
- The France market is expected to grow at a CAGR of 13.2% from 2024 to 2030.
- In terms of segment, alzheimer's disease was the largest revenue generating application in 2023.
- Alzheimer's Disease is the most lucrative application segment registering the fastest growth during the forecast period.
Immunoassay for neurological biomarkers market data book summary
| Market revenue in 2023 | USD 330.6 million |
| Market revenue in 2030 | USD 786.5 million |
| Growth rate | 13.2% (CAGR from 2023 to 2030) |
| Largest segment | Alzheimer's disease |
| Fastest growing segment | Alzheimer's Disease |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder |
| Key market players worldwide | Qiagen NV, Abbott Laboratories, Merck & Co Inc, Johnson & Johnson, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Sysmex Corp, Merck KGaA, Roche Holding AG, Nimble Therapeutics |
Other key industry trends
- In terms of revenue, France accounted for 4.1% of the global immunoassay for neurological biomarkers market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany immunoassay for neurological biomarkers market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 706.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunoassay For Neurological Biomarkers Market Scope
Immunoassay For Neurological Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France immunoassay for neurological biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunoassay for neurological biomarkers market will help companies and investors design strategic landscapes.
Alzheimer's disease was the largest segment with a revenue share of 35.93% in 2023. Horizon Databook has segmented the France immunoassay for neurological biomarkers market based on alzheimer's disease, parkinson's disease, multiple sclerosis, autism spectrum disorder covering the revenue growth of each sub-segment from 2018 to 2030.
France is expected to witness significant growth over the forecast period owing to research initiatives focusing on the development of potential diagnostics for neurological diseases in the region. Moreover, increasing research for the development of novel neurological biomarker products in the country is anticipated to support market growth over the forecast period.
For instance, researchers from the institute Pasteur, CNRS, CEA, Inserm, Pierre and Marie Curie, Paris Descartes University, and Roche Group jointly developed two antibodies—anti-tau protein and against-AB—for identifying neurofibrillary tangles and amyloid plaques in patients suffering from Alzheimer’s disease.
The development of these two antibodies is anticipated to boost the R&D of novel immunoassay products for the diagnosis of neurological diseases. The National Agency for Safety of Medicines and Health Products (ANSM) is responsible for the approval of pharmaceuticals, biological products, cosmetics, and medical devices.
Reasons to subscribe to France immunoassay for neurological biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France immunoassay for neurological biomarkers market databook
-
Our clientele includes a mix of immunoassay for neurological biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France immunoassay for neurological biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into France immunoassay for neurological biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France immunoassay for neurological biomarkers market size, by application, 2018-2030 (US$M)
France Immunoassay For Neurological Biomarkers Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
